Ranbaxy to supply oseltamivir capsules to US

NEW DELHI: Ranbaxy Laboratories said it was prepared to provide oseltamivir phosphate capsules (generic version of Tamiflu) to the US healthcare system to ward off threat from avian flu ife quarter last fiscal.

Domestic sales went up by 12 per cent during the quarter ended September 30, against 2.8 million tonnes in the same quarter previous fiscal.

“Domestic sales went up by 12 per cent during the quarter ended September 30, against 2.8 million tonnes in the same quarter previous fiscal.